Anti	O
-	O
metastasis	O
effects	O
of	O
gallic	O
acid	O
on	O
gastric	B-Cell
cancer	I-Cell
cells	I-Cell
involves	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activity	O
and	O
downregulation	O
of	O
PI3K	O
/	O
AKT	O
/	O
small	O
GTPase	O
signals	O
.	O

Polyphenols	O
are	O
natural	O
antioxidants	O
that	O
are	O
thought	O
to	O
contribute	O
to	O
prevention	O
of	O
cardiovascular	B-Anatomical_system
disease	O
and	O
malignancy	B-Cancer
.	O

Although	O
many	O
studies	O
have	O
been	O
carried	O
out	O
to	O
investigate	O
the	O
chemopreventive	O
role	O
of	O
flavonoids	O
,	O
less	O
attention	O
has	O
been	O
focused	O
on	O
phenolic	O
acids	O
.	O

In	O
this	O
study	O
,	O
the	O
aim	O
was	O
to	O
investigate	O
the	O
effect	O
of	O
phenolic	O
acids	O
found	O
abundantly	O
in	O
vegetables	B-Organism_subdivision
,	O
i	O
.	O
e	O
.	O
gallic	O
acid	O
(	O
GA	O
)	O
,	O
caffeic	O
acid	O
(	O
CA	O
)	O
and	O
protocatechuic	O
acid	O
(	O
PCA	O
)	O
,	O
on	O
the	O
inhibition	O
of	O
gastric	B-Cell
adenocarcinoma	I-Cell
(	I-Cell
AGS	I-Cell
)	I-Cell
cell	I-Cell
metastasis	O
.	O

The	O
results	O
showed	O
0	O
.	O
01	O
mM	O
GA	O
induced	O
the	O
same	O
level	O
of	O
cell	B-Cell
toxicity	O
as	O
4	O
.	O
0mM	O
PCA	O
.	O

Using	O
wound	B-Pathological_formation
-	O
healing	O
assay	O
and	O
Boyden	O
chamber	O
assay	O
,	O
GA	O
had	O
potent	O
inhibitory	O
effects	O
on	O
AGS	B-Cell
cell	I-Cell
migration	O
.	O

The	O
expression	O
of	O
MMP	O
-	O
2	O
/	O
9	O
of	O
AGS	B-Cell
cells	I-Cell
was	O
inhibited	O
by	O
2	O
.	O
0	O
microM	O
of	O
GA	O
.	O

It	O
is	O
possible	O
that	O
the	O
suppressive	O
effect	O
of	O
GA	O
on	O
MMP	O
-	O
2	O
/	O
9	O
might	O
involve	O
the	O
inhibition	O
of	O
NF	O
-	O
kappaB	O
activity	O
.	O

Multiple	O
proteins	O
involved	O
in	O
metastasis	O
and	O
the	O
cytoskeletal	B-Cellular_component
reorganization	O
signal	O
pathway	O
,	O
including	O
Ras	O
,	O
Cdc42	O
,	O
Rac1	O
,	O
RhoA	O
,	O
RhoB	O
,	O
PI3K	O
and	O
p38MAPK	O
,	O
were	O
also	O
inhibited	O
by	O
GA	O
.	O

Furthermore	O
,	O
immunoreactivity	O
assay	O
of	O
cytoskeletal	B-Cellular_component
F	O
-	O
actin	O
demonstrated	O
a	O
significant	O
inhibitory	O
effect	O
of	O
GA	O
treatment	O
.	O

In	O
conclusion	O
,	O
GA	O
may	O
have	O
the	O
potential	O
to	O
be	O
an	O
effective	O
agent	O
for	O
prevention	O
and	O
treatment	O
of	O
gastric	B-Cancer
cancer	I-Cancer
metastasis	O
.	O

